Stockreport

Biopharma 2018: Growth At A Reasonable Cost (GARC) [Seeking Alpha]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Summary I maintain that the prospects for the biopharmaceutical industry are extremely favorable, driven by new drug discovery in oncology, hematology and inflammato [Read more]